Published in Clin Infect Dis on February 01, 2000
Complete genome sequence and comparative genomic analysis of an emerging human pathogen, serotype V Streptococcus agalactiae. Proc Natl Acad Sci U S A (2002) 5.28
Removal of group B streptococci colonizing the vagina and oropharynx of mice with a bacteriophage lytic enzyme. Antimicrob Agents Chemother (2005) 1.79
Early-onset neonatal sepsis. Clin Microbiol Rev (2014) 1.53
Comparison of DNA dot blot hybridization and lancefield capillary precipitin methods for group B streptococcal capsular typing. J Clin Microbiol (2004) 1.53
Multilocus sequence types associated with neonatal group B streptococcal sepsis and meningitis in Canada. J Clin Microbiol (2009) 1.51
Group B streptococcal conjugate vaccines. Arch Dis Child (2003) 1.32
Group B streptococcus and early-onset sepsis in the era of maternal prophylaxis. Pediatr Clin North Am (2009) 1.14
Molecular characterization of nontypeable group B streptococcus. J Clin Microbiol (2006) 1.14
DNA polymorphism and molecular subtyping of the capsular gene cluster of group B streptococcus. J Clin Microbiol (2005) 1.11
Serine-rich repeat proteins and pili promote Streptococcus agalactiae colonization of the vaginal tract. J Bacteriol (2011) 1.10
Molecular epidemiology of macrolide resistance in neonatal bloodstream isolates of group B streptococci. J Clin Microbiol (2003) 1.09
Serotype IV and invasive group B Streptococcus disease in neonates, Minnesota, USA, 2000-2010. Emerg Infect Dis (2013) 1.06
DNA macrorestriction analysis of nontypeable group B streptococcal isolates: clonal evolution of nontypeable and type V isolates. J Clin Microbiol (2005) 1.03
Immune activation and suppression by group B streptococcus in a murine model of urinary tract infection. Infect Immun (2011) 0.99
Characterization of invasive group B streptococcus strains from the greater Toronto area, Canada. J Clin Microbiol (2014) 0.99
Interaction of neonatal phagocytes with group B streptococcus: recognition and response. Infect Immun (2006) 0.99
Combining microarray technology and molecular epidemiology to identify genes associated with invasive group B streptococcus. Interdiscip Perspect Infect Dis (2008) 0.97
Immune modulation by group B Streptococcus influences host susceptibility to urinary tract infection by uropathogenic Escherichia coli. Infect Immun (2012) 0.97
Clonal analysis of colonizing group B Streptococcus, serotype IV, an emerging pathogen in the United States. J Clin Microbiol (2010) 0.94
Maternal antibody at delivery protects neonates from early onset group B streptococcal disease. J Infect Dis (2013) 0.92
Emergence of Serotype IV Group B Streptococcus Adult Invasive Disease in Manitoba and Saskatchewan, Canada, Is Driven by Clonal Sequence Type 459 Strains. J Clin Microbiol (2015) 0.91
Analysis of two-component systems in group B Streptococcus shows that RgfAC and the novel FspSR modulate virulence and bacterial fitness. MBio (2014) 0.90
Type IV neonatal early-onset group B streptococcal disease in a United States hospital. J Clin Microbiol (2007) 0.89
Rectal colonization by group B Streptococcus as a predictor of vaginal colonization. Am J Obstet Gynecol (2009) 0.88
Transcriptional and proteomic profiles of group B Streptococcus type V reveal potential adherence proteins associated with high-level invasion. Infect Immun (2007) 0.87
The frequency of genes encoding three putative group B streptococcal virulence factors among invasive and colonizing isolates. BMC Infect Dis (2006) 0.86
Burden of invasive group B Streptococcus disease and early neurological sequelae in South African infants. PLoS One (2015) 0.86
Distribution of novel and previously investigated virulence genes in colonizing and invasive isolates of Streptococcus agalactiae. Epidemiol Infect (2006) 0.85
Induction and termination of inflammatory signaling in group B streptococcal sepsis. Immunol Rev (2008) 0.84
Emergence of invasive serotype VIII group B streptococcal infections in Denmark. J Clin Microbiol (2003) 0.82
Neonatal infections: group B streptococcus. BMJ Clin Evid (2014) 0.80
Severity of group B streptococcal arthritis in selected strains of laboratory mice. Infect Immun (2001) 0.77
Anchors away: contribution of a glycolipid anchor to bacterial invasion of host cells. J Clin Invest (2005) 0.77
Early detection of neonatal group B streptococcus sepsis and the possible diagnostic utility of IL-6, IL-8, and CD11b in a human umbilical cord blood in vitro model. Infect Drug Resist (2016) 0.75
Neonatal infections: group B streptococcus. BMJ Clin Evid (2010) 0.75
Gene Expression Profiling of Tuberculous Meningitis Co-infected with HIV. J Proteomics Bioinform (2012) 0.75
Risk factors for group B streptococcal disease in neonates of mothers with negative antenatal testing. J Perinatol (2016) 0.75
Immunity to uropathogens: the emerging roles of inflammasomes. Nat Rev Urol (2017) 0.75
Neonatal infections: group B streptococcus. BMJ Clin Evid (2008) 0.75
Expression of group B protective surface protein (BPS) by invasive and colonizing isolates of group B streptococci. Curr Microbiol (2014) 0.75
Reliability of diagnosing bacterial vaginosis is improved by a standardized method of gram stain interpretation. J Clin Microbiol (1991) 20.49
Association between bacterial vaginosis and preterm delivery of a low-birth-weight infant. The Vaginal Infections and Prematurity Study Group. N Engl J Med (1995) 8.89
Relation of pooled logistic regression to time dependent Cox regression analysis: the Framingham Heart Study. Stat Med (1990) 7.00
Transmission of group B streptococci among parturient women and their neonates. J Pediatr (1973) 6.86
Trichomonas vaginalis associated with low birth weight and preterm delivery. The Vaginal Infections and Prematurity Study Group. Sex Transm Dis (1997) 6.64
Suppurative meningitis due to streptococci of Lancefield group B: a study of 33 infants. J Pediatr (1973) 6.29
Correlation of maternal antibody deficiency with susceptibility to neonatal group B streptococcal infection. N Engl J Med (1976) 5.78
Prevention of bacterial endocarditis. Recommendations by the American Heart Association. JAMA (1997) 5.24
Diagnosis and management of infective endocarditis and its complications. Circulation (1999) 4.77
Epidemiology of sepsis syndrome in 8 academic medical centers. JAMA (1997) 4.49
Antigenic specificity of opsonophagocytic antibodies in rabbit anti-sera to group B streptococci. J Immunol (1977) 4.46
Selective broth medium for isolation of group B streptococci. Appl Microbiol (1973) 4.42
Validation of patient reports, automated pharmacy records, and pill counts with electronic monitoring of adherence to antihypertensive therapy. Med Care (1999) 4.35
Relationships of vaginal Lactobacillus species, cervical Chlamydia trachomatis, and bacterial vaginosis to preterm birth. Obstet Gynecol (1988) 4.23
Using automated medical records for rapid identification of illness syndromes (syndromic surveillance): the example of lower respiratory infection. BMC Public Health (2001) 4.05
The incidence of herpes zoster. Arch Intern Med (1995) 3.87
Contraindicated use of cisapride: impact of food and drug administration regulatory action. JAMA (2000) 3.81
Group B streptococcal infections in infants. The importance of the various serotypes. JAMA (1974) 3.71
Diagnosis and clinical manifestations of bacterial vaginosis. Am J Obstet Gynecol (1988) 3.66
Typing of group B streptococci: comparison of pulsed-field gel electrophoresis and conventional electrophoresis. J Clin Microbiol (1993) 3.52
The role of specific antibody in alternative complement pathway-mediated opsonophagocytosis of type III, group B Streptococcus. J Exp Med (1980) 3.48
The normal vaginal flora, H2O2-producing lactobacilli, and bacterial vaginosis in pregnant women. Clin Infect Dis (1993) 3.32
Discontinuation of antihyperlipidemic drugs--do rates reported in clinical trials reflect rates in primary care settings? N Engl J Med (1995) 3.29
Bacterial vaginosis as a risk factor for post-cesarean endometritis. Obstet Gynecol (1990) 3.28
Capsular sialic acid prevents activation of the alternative complement pathway by type III, group B streptococci. J Immunol (1982) 3.23
Nontypable Haemophilus influenzae (biotype 4) as a neonatal, maternal, and genital pathogen. Rev Infect Dis (1983) 3.23
Serotype distribution of invasive group B streptococcal isolates in Maryland: implications for vaccine formulation. Maryland Emerging Infections Program. J Infect Dis (1998) 3.18
Immunization of pregnant women with a polysaccharide vaccine of group B streptococcus. N Engl J Med (1988) 3.14
Active oxygen in plant pathogenesis. Annu Rev Phytopathol (1995) 3.02
Clinical manifestations of vaginal trichomoniasis. JAMA (1989) 2.97
Evidence for the retraining of sensation after stroke: a systematic review. Clin Rehabil (2009) 2.96
Reducing vancomycin use utilizing a computer guideline: results of a randomized controlled trial. J Am Med Inform Assoc (1998) 2.96
Cutaneous disease and drug reactions in HIV infection. N Engl J Med (1993) 2.89
Self-collection of vaginal swabs for the detection of Chlamydia, gonorrhea, and trichomoniasis: opportunity to encourage sexually transmitted disease testing among adolescents. Sex Transm Dis (2001) 2.86
Molecular cloning of a Pseudomonas syringae pv. syringae gene cluster that enables Pseudomonas fluorescens to elicit the hypersensitive response in tobacco plants. J Bacteriol (1988) 2.84
Intramuscular versus oral antibiotic therapy for the prevention of meningitis and other bacterial sequelae in young, febrile children at risk for occult bacteremia. J Pediatr (1994) 2.79
Association of intravenous lipid emulsion and coagulase-negative staphylococcal bacteremia in neonatal intensive care units. N Engl J Med (1990) 2.78
A model-adjusted space-time scan statistic with an application to syndromic surveillance. Epidemiol Infect (2005) 2.65
A mutation in the voltage-gated sodium channel gene associated with pyrethroid resistance in Latin American Aedes aegypti. Insect Mol Biol (2007) 2.60
Immunochemical characterization of the "native" type III polysaccharide of group B Streptococcus. J Exp Med (1976) 2.55
Group B streptococcal Ibc protein antigen: distribution of two determinants in wild-type strains of common serotypes. J Clin Microbiol (1984) 2.55
Mortality and costs of acute renal failure associated with amphotericin B therapy. Clin Infect Dis (2001) 2.51
Serotypes VI and VIII predominate among group B streptococci isolated from pregnant Japanese women. J Infect Dis (1999) 2.50
Involvement of plasma membrane calcium influx in bacterial induction of the k/h and hypersensitive responses in tobacco. Plant Physiol (1990) 2.46
Neonatal sepsis caused by a new group B streptococcal serotype. J Pediatr (1993) 2.45
Inhaled steroids and the risk of hospitalization for asthma. JAMA (1997) 2.45
Antenatal microbiologic and maternal risk factors associated with prematurity. Am J Obstet Gynecol (1990) 2.44
Detection of HIV DNA in cervical and vaginal secretions. Prevalence and correlates among women in Nairobi, Kenya. JAMA (1993) 2.41
Reducing antibiotic use in children: a randomized trial in 12 practices. Pediatrics (2001) 2.41
Microcapsule of type III strains of group B Streptococcus: production and morphology. Infect Immun (1976) 2.38
Surgical site infections occurring after hospital discharge. J Infect Dis (1996) 2.35
The association of occult amniotic fluid infection with gestational age and neonatal outcome among women in preterm labor. Obstet Gynecol (1992) 2.32
Prevention of bacterial endocarditis. Recommendations by the American Heart Association. Circulation (1997) 2.32
Diagnosis and therapy of Kawasaki disease in children. Circulation (1993) 2.32
Clinical uses of intravenous immunoglobulins. Ann Intern Med (1990) 2.29
Characteristics of three vaginal flora patterns assessed by gram stain among pregnant women. Vaginal Infections and Prematurity Study Group. Am J Obstet Gynecol (1992) 2.27
Quantitative determination of antibody to capsular polysaccharide in infection with type III strains of group B Streptococcus. J Clin Invest (1977) 2.23
Mortality associated with nosocomial urinary-tract infection. N Engl J Med (1982) 2.23
Determinants of preterm birth rates in Canada from 1981 through 1983 and from 1992 through 1994. N Engl J Med (1998) 2.21
Bacterial vaginosis and HIV seroprevalence among female commercial sex workers in Chiang Mai, Thailand. AIDS (1995) 2.19
Inhibitors of hydroxymethylglutaryl-coenzyme A reductase and risk of fracture among older women. Lancet (2000) 2.17
Thoughts on teaching medicine. Br Med J (1965) 2.17
The relationship of hydrogen peroxide-producing lactobacilli to bacterial vaginosis and genital microflora in pregnant women. Obstet Gynecol (1992) 2.15
Serious falls in hospitalized patients: correlates and resource utilization. Am J Med (1995) 2.15
Association of elevated levels of extracellular neuraminidase with clinical isolates of type III group B streptococci. Infect Immun (1978) 2.15
Comparison of bacteriological methods for the isolation of group of B Streptococcus from vaginal cultures. J Clin Microbiol (1976) 2.14
The relationship of amniotic fluid cytokines and preterm delivery, amniotic fluid infection, histologic chorioamnionitis, and chorioamnion infection. Obstet Gynecol (1993) 2.12
Epidemiology of group-B streptococcal carriage in pregnant women and newborn infants. J Med Microbiol (1977) 2.12
Bacterial colonization of the vagina during pregnancy in four ethnic groups. Vaginal Infections and Prematurity Study Group. Am J Obstet Gynecol (1996) 2.10
The epidemiology of varicella and its complications. J Infect Dis (1995) 2.10
Changing epidemiology of group B streptococcal colonization. Pediatrics (1999) 2.09
Capsular K1 polysaccharide of Escherichia coli: relationship to virulence in newborn rats and resistance to phagocytosis. Infect Immun (1979) 2.08
Immunodeterminant specificity of human immunity to type III group B streptococcus. J Exp Med (1979) 2.06
Immune response to type III group B streptococcal polysaccharide-tetanus toxoid conjugate vaccine. J Clin Invest (1996) 2.05
The 1997 AAP guidelines for prevention of early-onset group B streptococcal disease. American Academy of Pediatrics. Pediatrics (1997) 2.04
Antimicrobial use in defined populations of infants and young children. Arch Pediatr Adolesc Med (2000) 2.01
Capsular polysaccharide types of group B streptococcal isolates from neonates with early-onset systemic infection. J Infect Dis (1998) 2.01
Predictive value of quantitative plasma HIV RNA and CD4+ lymphocyte count in HIV-infected infants and children. JAMA (1998) 2.00
Antimicrobial susceptibilities of group B streptococci isolated between 1992 and 1996 from patients with bacteremia or meningitis. Antimicrob Agents Chemother (1998) 2.00
Epidemiology of community-acquired Clostridium difficile-associated diarrhea. J Infect Dis (1994) 1.96
Immunogenicity of polysaccharides from type III, group B Streptococcus. J Clin Invest (1978) 1.95
Reforming the core clerkship in internal medicine: the SGIM/CDIM Project. Society of General Internal Medicine/Clerkship Directors in Internal Medicine. Ann Intern Med (2001) 1.91
An algorithm to match registries with minimal disclosure of individual identities. Public Health Rep (1999) 1.90
Restriction endonuclease analysis of human and bovine group B streptococci for epidemiologic study. J Clin Microbiol (1989) 1.87
Supplementing tuberculosis surveillance with automated data from health maintenance organizations. Emerg Infect Dis (2000) 1.86
Role of antibody to native type III polysaccharide of group B Streptococcus in infant infection. Pediatrics (1981) 1.83
The sequelae of herpes zoster. Arch Intern Med (1997) 1.82
Dynamics of Escherichia coli infection and meningitis in infant rats. Infect Immun (1978) 1.82
Moxalactam therapy of infections caused by cephalothin-resistant bacteria: influence of serum inhibitory activity on clinical response and acquisition of antibiotic resistance during therapy. Antimicrob Agents Chemother (1981) 1.81
Influences on hospital admission for asthma in south Asian and white adults: qualitative interview study. BMJ (2001) 1.80
Risk factors for postherpetic neuralgia. Arch Intern Med (1997) 1.79
Glyoxylate bypass enzymes in Yersinia species and multiple forms of isocitrate lyase in Yersinia pestis. J Bacteriol (1981) 1.78
Persistent bacteremia due to coagulase-negative staphylococci in low birth weight neonates. Pediatrics (1989) 1.78